Eight Roads

Eight Roads is a global venture capital firm, established in 1969, that invests in technology and healthcare companies across Asia, Europe, Israel, and the United States. It manages over $11 billion in assets through various funds, including Eight Roads Ventures China, Europe, India, and Japan. The firm focuses on early venture, growth capital, and growth stage investments, typically committing between $1.29 million to $30 million per company. Eight Roads seeks minority and majority stakes, often taking a board seat, and has invested in over 500 companies such as Alibaba, Chewy, and Toast. It operates as the proprietary investment arm of Fidelity International Limited.

Umang Agarwal

Principal

Sanjay Aggarwal

Venture Partner

Hiroki Ashida

Vice President

Daniel Auerbach

Senior Managing Partner and Head of Global Ventures

Vytautas Balsys

Partner

Helena Barman

Investor

Virginia Bassano

Vice President

Shirish Belapure

Venture Partner

Daniel Benjamin

Associate

Betty Cai

Partner

Ted Chua

Senior Partner

Kevin Du

Senior Associate

Raj Dugar

Managing Partner, India

Martin Ericsson

Vice President

Tamina Fogelberg

Associate

Siddhant Gandhi

Associate

Elaine Gao

Senior Associate

Antonin Gury-Coupier

Vice President

Davor Hebel

Managing Partner and Head of Europe

April Hu

Vice President

Tao Huang

Principal

Tammy Huang

Senior Associate

Tao Huang

Principal

Allen Huo

Vice President

Abhishek Jain

Vice President

Zang Jialun

Partner

Junichi Murata

Partner

Deepak Kanvinde

Venture Partner

Michiko Kohyama

Vice President

Shinichiro Komoto

Partner

Kavish Kothari

Principal

Chintan Kothari

Partner

Thomas Lin

Vice President

Xin Liu

Partner

Allen Liu

Senior Associate

Maneesh Menon

Principal

Sophie Meralli

Vice President

Chersy Miao

Principal

David Milstein

Managing Partner and Head of Japan

Jens Neisius

Vice President

Dan O'Toole

Vice President

Yosuke Ouchi

Principal

Delphine Qiu

Principal

Eyal Rabinovich

Principal

Laura Salesse

Senior Associate

Fuga Sawada

Senior Associate

Shawn Shen

Partner

Sagar Sheth

Vice President

Lei Shi Ph.D

Partner

Arjun Singh

Senior Associate

Michael Stephanblome

Venture Partner

Liena Suzuki MD

Principal

Aditya Systla

Partner

Jarlon Tsang

Managing Partner and Head of China

Ashish Venkataramani

Partner

Ashish Venkataramani

Partner

Bo Wang

Senior Associate

He Wang

Vice President

Nancy Xu

Vice President

Cody Yin Ph.D

Partner

Zhang Yixiao

Executive Director

Yuan Yuan

Principal

Alston Zecha

Partner

Gordon Zhang

Partner

Haoming Zhang

Vice President

Feng Zhao Ph.D

Partner

Weimin Liu Ph.D

Partner

Past deals in Personal Health

Eleos Health

Series C in 2025
Eleos Health is a technology company that specializes in artificial intelligence-driven solutions for the behavioral health sector. It has developed a voice technology platform designed to enhance clinicians' decision-making by providing real-time insights during mental health sessions. This AI-powered system operates in the background, analyzing voice interactions and other data parameters to generate valuable information about patients. By leveraging this technology, Eleos Health aims to facilitate personalized care, ensuring that mental health professionals can deliver timely and cost-effective support tailored to individual needs.

Spry

Series B in 2024
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.

Pelago

Series C in 2024
Pelago, formerly known as Quit Genius, is a leading virtual clinic focused on substance use management, specializing in support for individuals struggling with addictions to tobacco, alcohol, and opioids. The company provides a comprehensive approach to substance use support, offering education, management skills, and opportunities for positive change. Pelago's platform utilizes cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) to deliver accessible and effective support tailored to individual needs. This service is designed to integrate seamlessly with health plans, pharmacy benefit managers, and wellness platforms, enabling employers to offer on-demand, personalized assistance to employees seeking healthier lifestyles. To date, Pelago has successfully assisted over 750,000 members in managing their substance use and improving their overall well-being. The platform features engaging resources such as animated videos, interactive exercises, and audio sessions, empowering users to confront their addictions in a personalized manner with the guidance of a coach.

Everheal

Venture Round in 2024
Everheal is a health-tech startup focused on providing comprehensive support for women during the pre-conception, pregnancy, and post-partum periods. The company operates a maternity care center and an integrated platform designed to enhance clinical outcomes for mothers. Everheal offers gynecologists an all-in-one solution that includes patient support features, technology-assisted service packages, an e-store, and monitoring devices. Key services encompass nutrition tracking, video consultations, and automated vital sign monitoring for patients dealing with gestational diabetes or hypertension. By consolidating multiple healthcare services into a single platform, Everheal aims to improve the overall maternal healthcare experience.

Eleos Health

Series B in 2023
Eleos Health is a technology company that specializes in artificial intelligence-driven solutions for the behavioral health sector. It has developed a voice technology platform designed to enhance clinicians' decision-making by providing real-time insights during mental health sessions. This AI-powered system operates in the background, analyzing voice interactions and other data parameters to generate valuable information about patients. By leveraging this technology, Eleos Health aims to facilitate personalized care, ensuring that mental health professionals can deliver timely and cost-effective support tailored to individual needs.

NOCD

Series B in 2023
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.

Spry

Series A in 2022
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.

Eleos Health

Series A in 2022
Eleos Health is a technology company that specializes in artificial intelligence-driven solutions for the behavioral health sector. It has developed a voice technology platform designed to enhance clinicians' decision-making by providing real-time insights during mental health sessions. This AI-powered system operates in the background, analyzing voice interactions and other data parameters to generate valuable information about patients. By leveraging this technology, Eleos Health aims to facilitate personalized care, ensuring that mental health professionals can deliver timely and cost-effective support tailored to individual needs.

TreeENT

Series A in 2022
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.

NOCD

Series B in 2021
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.

Oviva

Series C in 2021
Oviva UK Limited, founded in 2013 and headquartered in London, offers digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. The company has developed a unique platform that combines a smartphone app with learning portals, enabling personalized behavior change programs led by qualified dietitians. This innovative approach allows patients to manage their health effectively without needing to attend in-person clinic appointments, thus reducing healthcare costs by preventing complications associated with these conditions. By providing tailored nutritional advice and coaching through technology, Oviva supports patients in achieving improved health outcomes.

Patient 21

Series B in 2021
Patient21 operates a health platform focused on improving the doctor-patient connection, which they view as essential for effective healthcare. The company aims to modernize the healthcare experience by addressing the fragmented and outdated processes currently prevalent in the industry. By leveraging technology, Patient21 enhances dental clinics with management software that streamlines administrative tasks such as appointment scheduling and patient data management. They also provide electronic health records (EHR) to healthcare professionals, which helps improve diagnostic quality and reduce costs. Through these innovations, Patient21 seeks to facilitate better decision-making for both patients and physicians, ultimately promoting a more personalized and collaborative approach to healthcare.

OZiva

Series B in 2021
OZiva is a plant-based clean nutrition brand that specializes in producing organic nutritional products aimed at promoting healthier lifestyle choices. The company offers a diverse range of items, including those focused on fitness, hair and skin health, and both men's and women's wellness. OZiva distinguishes itself by integrating ancient Ayurvedic principles with modern micronutrient science, creating a comprehensive nutrition and fitness ecosystem. This approach not only addresses everyday nutritional needs but also fosters a supportive digital community for individuals pursuing healthier living. Through its offerings, OZiva aims to make healthy dietary planning convenient and accessible for its customers.

Oviva

Series B in 2020
Oviva UK Limited, founded in 2013 and headquartered in London, offers digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. The company has developed a unique platform that combines a smartphone app with learning portals, enabling personalized behavior change programs led by qualified dietitians. This innovative approach allows patients to manage their health effectively without needing to attend in-person clinic appointments, thus reducing healthcare costs by preventing complications associated with these conditions. By providing tailored nutritional advice and coaching through technology, Oviva supports patients in achieving improved health outcomes.

TreeENT

Series A in 2019
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.

Oviva

Series A in 2017
Oviva UK Limited, founded in 2013 and headquartered in London, offers digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. The company has developed a unique platform that combines a smartphone app with learning portals, enabling personalized behavior change programs led by qualified dietitians. This innovative approach allows patients to manage their health effectively without needing to attend in-person clinic appointments, thus reducing healthcare costs by preventing complications associated with these conditions. By providing tailored nutritional advice and coaching through technology, Oviva supports patients in achieving improved health outcomes.

8fit

Series A in 2017
8fit is a fitness application that aims to transform users' health and wellness journeys by offering personalized solutions. With a user base of over 20 million worldwide, the app provides custom workout plans that can be performed at home without the need for equipment, as well as tailored meal plans. By incorporating tools for weight tracking and progress monitoring, 8fit supports individuals in achieving their unique fitness goals. The company recognizes the challenges people face in their pursuit of health and emphasizes a balanced approach that prioritizes sustainable habits over quick fixes. By fostering an engaging and approachable environment, 8fit helps users navigate their paths to healthier lifestyles.

Oviva

Venture Round in 2016
Oviva UK Limited, founded in 2013 and headquartered in London, offers digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. The company has developed a unique platform that combines a smartphone app with learning portals, enabling personalized behavior change programs led by qualified dietitians. This innovative approach allows patients to manage their health effectively without needing to attend in-person clinic appointments, thus reducing healthcare costs by preventing complications associated with these conditions. By providing tailored nutritional advice and coaching through technology, Oviva supports patients in achieving improved health outcomes.

Cipla Health

Venture Round in 2016
Cipla Health is a pharmaceutical company dedicated to developing and commercializing consumer healthcare products. It specializes in creating over-the-counter medicines, including nicotine replacement therapy gum, cough lozenges, immunity booster supplements, and pregnancy care medicines. By focusing on these areas, Cipla Health aims to enhance the healthcare experience for patients and consumers alike. Its commitment to providing accessible and effective healthcare solutions underscores its role in the wellness sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.